Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. April 2026 23:29 ET | Quelle: NeuroSalt

NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification

What a 2026 ingredient review of NeuroSalt's botanical nerve formula found — and the consumer verification questions most coverage skips.
10. April 2026 22:53 ET | Quelle: Pulsetto

Pulsetto Claims Evaluated: 2026 Update on the Pulsetto Vagus Nerve Stimulator, Features, Pricing, and Consumer Use Considerations

Pulsetto vagus nerve stimulator 2026 update covering Lite vs FIT, pricing context, FCC certification, and consumer wellness use considerations.
10. April 2026 22:00 ET | Quelle: AlphaPepe

Crypto News: AlphaPepe Announces $800k Raised While Bitcoin Price Prediction Targets $80K Breakout After Global Ceasefire

MONACO, April 10, 2026 (GLOBE NEWSWIRE) -- AlphaPepe has crossed $800,000 in presale capital raised and the pace is accelerating faster than any previous stage. Capital is entering at a rate that...
10. April 2026 21:13 ET | Quelle: Emma

Emma Relief Claims Evaluated: Rising Consumer Interest in Gut Health Formulas for Bloating and Digestive Support in 2026

Ingredient context, consumer considerations, and 2026 category positioning for Emma Relief, the daily gut health formula from Enclave BioActives.
10. April 2026 20:34 ET | Quelle: Hewelth

Hewelth Claims Evaluated: Consumer Overview of BioClear Toenail Fungus Device, ReliefChain, TurboTwist and the Full Hewelth At-Home Wellness Lineup

Hewelth Claims Evaluated covers BioClear toenail fungus device, ReliefChain, TurboTwist and full Hewelth consumer wellness product lineup.
10. April 2026 19:41 ET | Quelle: Gentle Patches

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

Gentle Patches draws rising 2026 consumer interest as the pill-free transdermal wellness patch lineup highlights ingredient and policy details.
10. April 2026 19:12 ET | Quelle: Glo & Spa-rkle Aesthetics and Medical Spa

Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas

Lubbock, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Glo & Spa-rkle Aesthetics and Medical Spa, a leader in aesthetic and wellness services in the region, is thrilled to announce the Grand opening of...
10. April 2026 18:54 ET | Quelle: IVY Rx

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

IVY Rx releases 2026 compounded GLP-1 telehealth program information covering pricing tiers, clinician access, and pharmacy fulfillment details.
10. April 2026 17:13 ET | Quelle: ReadyRx

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

ReadyRx's 2026 update details prescription NAD+ nasal spray and injection access, compounded therapy structure, pricing, and clinician eligibility.
10. April 2026 16:16 ET | Quelle: Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc. Reports March 2026 Assets Under Management

MILWAUKEE, April 10, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of March 31, 2026 totaled...

Vorherige Seite

Nächste Seite